Lobo EV Technologies Ltd. (LOBO)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.38	0.47	0.18	0.61	0.07
Short-Term Investments	0.1	0.09	0.06	0.01	0.07
Cash & Short-Term Investments	1.48	0.56	0.24	0.62	0.14
Cash Growth	163.16%	133.36%	-61.13%	338.56%	-
Accounts Receivable	1.51	2.53	3.06	1.46	0.31
Receivables	1.51	2.53	6.57	4.11	3.04
Inventory	8.59	5.74	3.81	1.99	2.31
Prepaid Expenses	7.08	5.78	2.15	1.14	0.38
Restricted Cash	0.51	-	-	-	-
Other Current Assets	2.04	1.49	1.17	0.32	0.14
Total Current Assets	21.21	16.1	13.95	8.18	6.02
Property, Plant & Equipment	1.77	1.65	1.55	0.41	0.48
Long-Term Investments	-	-	-	1.57	-
Other Intangible Assets	0.87	1.92	1.44	1.11	0.03
Long-Term Deferred Tax Assets	0.18	-	-	-	-
Total Assets	24.02	19.67	16.94	11.27	6.53
Accounts Payable	2.22	0.93	1.8	0.86	1.31
Accrued Expenses	0.66	6.76	5.4	4	2.03
Short-Term Debt	0.86	1.67	1.86	1.14	0.02
Current Portion of Leases	0.77	0.36	0.22	0.02	0.04
Current Income Taxes Payable	0.27	1.69	1.38	1.06	0.47
Current Unearned Revenue	1.84	1.56	0.16	0.25	0.69
Other Current Liabilities	7.28	0.37	0.68	0.54	0.16
Total Current Liabilities	13.91	13.34	11.5	7.88	4.72
Long-Term Debt	0.24	0.14	-	0.22	-
Long-Term Leases	0.55	0.3	0.31	0.01	0.02
Other Long-Term Liabilities	-	0.01	0.05	0.04	-
Total Liabilities	14.7	13.79	11.86	8.16	4.74
Common Stock	0.01	0.01	0.01	0.01	0.05
Additional Paid-In Capital	8.78	3.01	3.01	1.81	-
Retained Earnings	1.11	3.01	2.04	0.97	1.53
Comprehensive Income & Other	-0.58	-0.38	-0.19	0.15	0.04
Total Common Equity	9.32	5.65	4.87	2.93	1.63
Minority Interest	-	0.23	0.21	0.18	0.16
Shareholders' Equity	9.32	5.88	5.08	3.12	1.79
Total Liabilities & Equity	24.02	19.67	16.94	11.27	6.53
Total Debt	2.42	2.47	2.39	1.4	0.08
Net Cash (Debt)	-0.94	-1.91	-2.15	-0.78	0.06
Net Cash Per Share	-0.13	-0.30	-0.34	-0.12	0.00
Filing Date Shares Outstanding	8.63	7.78	6.4	56.14	56.14
Total Common Shares Outstanding	8.63	6.4	6.4	56.14	56.14
Working Capital	7.3	2.76	2.45	0.3	1.3
Book Value Per Share	1.08	0.88	0.76	0.05	0.03
Tangible Book Value	8.45	3.74	3.43	1.82	1.6
Tangible Book Value Per Share	0.98	0.58	0.54	0.03	0.03
Machinery	0.05	0.26	0.25	0.25	0.3

Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q